NCT06825910

Brief Summary

This will be a randomized comparative study comparing the two supraglottic devices i-gel and Protector, intraoperatively, during minor urological procedures under general anesthesia in adult patient.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Feb 2025Dec 2026

First Submitted

Initial submission to the registry

January 12, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 13, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

1.9 years

First QC Date

January 12, 2025

Last Update Submit

April 24, 2026

Conditions

Keywords

LMAProtectorAirway Device EvaluationiGelAirway Device Comparison

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the airway sealing pressure of the Laryngeal Mask Airway (LMA) in neutral, extended, and extended-rotated head positions

    After the closure of the adjustable pressure limiting valve (APL) of the ventilation machine with a continuous fresh gas flow of 3L/min, a stethoscope for auscultation will be placed to the lateral position of the thyroid cartilage. Leak pressure is defined as the maximum airway pressure (Ppeak) during which no audible sound, like leak, is detected with the placement of the stethoscope at the thyroid cartilage. Successful placement of the laryngeal mask, will be confirmed right after insertion by the auscultation of both hemithoraces, the indication of capnography, and the ratio of inhaled to exhaled pulmonary volume

    Leak pressure will be measured in cmH2O within 60 seconds after successful placement: first in the neutral position, second in the extended position, and third in the extended rotated head position

Secondary Outcomes (4)

  • Success rate of each device for patients with a potential difficult airway according to the Simplified Airway Index

    The patients airway will be evaluated 24 hours before surgery based on the Simplified Airway Index for a potential difficult intubation

  • The time required for successful placement of the device

    Measured from the moment the clinician picks up the LMA device after induction of general anesthesia until the appearance of the first capnography waveform on the monitor with a maximum duration of 60 seconds per attempt and up to three attempts allowed

  • Number of attempts to successfully place a nasogastric tube through the specially designed channels of the laryngeal mask

    Each attempt, from the moment the clinician picks up the nasogastric tube, will have a time frame of 5 seconds. If the nasogastric tube is not placed within 5 seconds, the attempt will be considered a failure

  • Documentation of adverse events after the exertion

    Immediately after the exertion

Study Arms (2)

LMA igel group

ACTIVE COMPARATOR
Device: LMA igel

LMA protector group

ACTIVE COMPARATOR
Device: LMA protector

Interventions

LMA igelDEVICE

adults allocated to the LMA igel group, an LMA igel device will be inserted intraoperatively

LMA igel group

adults allocated to the LMA protector group, an LMA protector device will be inserted intraoperatively

LMA protector group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II
  • Patients older than 18 years
  • Procedures in supine and lithotomy position

You may not qualify if:

  • Tumors or anatomical anomalies of the upper airway
  • Known history of difficult intubation
  • Limited mouth opening less than 2cm
  • Decreased compliance of the lungs or the thoracic cage
  • Need of mechanical ventilation after the surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

SismanoglioGH

Athens, Greece

NOT YET RECRUITING

SismanoglioGH

Athens, Greece

RECRUITING

Central Study Contacts

Maria Zozefin Nikolopoulou

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Anesthesiology Resident at Sismanoglio General Hospital

Study Record Dates

First Submitted

January 12, 2025

First Posted

February 13, 2025

Study Start

February 1, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

April 27, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations